Literature DB >> 8102313

Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine.

J X Cai1, Y Y Ma, L Xu, X T Hu.   

Abstract

Repeated daily treatment with the catecholamine-depleting agent, reserpine, dramatically reduced performance on the delayed response task, a test of spatial working memory that depends upon the integrity of the prefrontal cortex. Delayed response performance fell from an average of 27.2/30 trials correct before reserpine treatment to an average of 20.4/30 trials correct after repeated reserpine administration. Injection of the alpha 2-adrenergic agonist, clonidine (0.0001-0.05 mg/kg), to chronic reserpine-treated monkeys significantly restored performance on the delayed response task; performance after an optimal dose averaged 27.8/30 trials correct. Clonidine's beneficial effects on delayed response performance were longlasting; monkeys remained improved for more than 24 h after a single clonidine injection. The finding that clonidine is efficacious in reserpinized animals supports the hypothesis that alpha 2-adrenergic agonists improve cognitive function through actions at postsynaptic, alpha 2-adrenergic receptors on non-adrenergic cells. In contrast to the delayed response task, reserpine had little effect on performance of a visual discrimination task, a reference memory task which does not depend on the prefrontal cortex. These results emphasize the importance of postsynaptic, alpha 2-adrenergic mechanisms in the regulation of working memory.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102313     DOI: 10.1016/0006-8993(93)91034-p

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

Review 2.  A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?

Authors:  Paul J Fitzgerald
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

Review 3.  Physiological approaches to understanding molecular actions on dorsolateral prefrontal cortical neurons underlying higher cognitive processing.

Authors:  Min Wang; Amy F T Arnsten
Journal:  Dongwuxue Yanjiu       Date:  2015-11-18

4.  Sensory responses of neurons in the medial septal area in conditions of modulation of theta activity using the alpha-2-adrenoreceptor agonist clonidine.

Authors:  V F Kichigina; E S Kutyreva; V V Sudnitsyn
Journal:  Neurosci Behav Physiol       Date:  2005-01

Review 5.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

Review 6.  Modulators in concert for cognition: modulator interactions in the prefrontal cortex.

Authors:  Lisa A Briand; Howard Gritton; William M Howe; Damon A Young; Martin Sarter
Journal:  Prog Neurobiol       Date:  2007-06-30       Impact factor: 11.685

7.  Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.

Authors:  S M Clinton; I L Sucharski; J M Finlay
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

8.  Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast.

Authors:  Neil Easton; Yasmene B Shah; Fiona H Marshall; Kevin C Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

9.  The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

Authors:  Amy F T Arnsten
Journal:  J Pediatr       Date:  2009-05-01       Impact factor: 4.406

10.  Effects of the noradrenergic neurotoxin DSP4 on spatial memory in the rat.

Authors:  T A Sontag; J Hauser; I Kaunzinger; M Gerlach; O Tucha; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.